Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2014
07/01/2014US8765145 LSA-5 liver stage and blood stage antigen of Plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria
07/01/2014US8765134 Methods for treating chronic obstructive pulmonary disease
07/01/2014US8765132 Human cytomegalovirus neutralizing antibodies and use thereof
07/01/2014US8765131 Methods of inhibiting alternative pathway complement activation with anti-factor D antibodies
07/01/2014US8765130 Antagonistic DR3 ligands
07/01/2014US8765124 Stabilized preparation containing protein
06/2014
06/26/2014WO2014100823A1 Anti-h7cr antibodies
06/26/2014WO2014100772A1 Antibodies that bind membrane-bound il1rap
06/26/2014WO2014100689A1 Anti-gdf15 antibodies
06/26/2014WO2014100602A1 Treatment of egf-receptor dependent pathologies
06/26/2014WO2014100600A2 Human anti-tau antibodies
06/26/2014WO2014100578A1 Peptides useful for modulating histone demethylase function
06/26/2014WO2014100565A1 Methods and compositions relating to treatment of cancer
06/26/2014WO2014100542A1 High-throughput antibody humanization
06/26/2014WO2014100435A1 Anti-notch3 antibodies
06/26/2014WO2014100079A1 Antibodies that bind to human programmed death ligand 1 (pd-l1)
06/26/2014WO2014099933A1 Sensitive multiplex immunoassay for soluble fibroblast growth factor receptors
06/26/2014WO2014099908A1 Methods for inhibiting viral infection in transplant patients
06/26/2014WO2014099669A1 Porcine parvovirus 5a, methods of use and vaccine
06/26/2014WO2014099391A1 Bmp-6 antibodies
06/26/2014WO2014098319A1 T-cell-specific humanized single fragment antibody delivery vehicle
06/26/2014WO2014098243A1 iPS/ES CELL-SPECIFIC ANTIBODY HAVING CYTOTOXICITY TO TARGET CELLS AND USE THEREOF
06/26/2014WO2014097932A1 Marker peptide for determining risk for hyperglycemia and use thereof
06/26/2014WO2014097762A1 Antibody to highly pathogenic avian influenza
06/26/2014WO2014097648A1 Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective
06/26/2014WO2014096672A1 Use of monoclonal antibodies for the treatment of inflammation and bacterial infections
06/26/2014WO2014096399A1 Manipulation of hairy and split 3 (hes3) and its regulators/mediators as a new anti-cancer strategy
06/26/2014WO2014096390A1 Single linker fabfv antibodies and methods of producing same
06/26/2014WO2014096386A1 Anti-hdac11 antibodies
06/26/2014WO2014096333A1 Anti-staphylococcal antibodies
06/26/2014WO2014096321A1 Antibodies specific to tau phosphorylated at serine 422 and uses for the treatment and diagnosis of tauopathies
06/26/2014WO2014096248A2 Biomarker methods and compositions
06/26/2014WO2014096163A1 New polypeptides
06/26/2014WO2014096051A1 Anti her2 antibody formulation
06/26/2014WO2014096015A1 Disulfide-linked multivalent mhc class i comprising multi-function proteins
06/26/2014WO2014095891A1 Method for detecting trichophytons and associated diseases
06/26/2014WO2014095808A1 Antibodies against il-1 beta
06/26/2014WO2014095088A1 Egfr targeted therapy of neurological disorders and pain
06/26/2014WO2014094957A1 Copolymers for protein precipitation
06/26/2014WO2014094799A1 Ubiquitin moieties as a means for prolonging serum half-life
06/26/2014WO2014094528A1 Compounds and methods for the treatment of cd20 positive diseases
06/26/2014WO2014094355A1 Compounds and methods for the treatment of egfr positive diseases
06/26/2014WO2014094353A1 Maytansinoid derivatives
06/26/2014WO2014094122A1 Treatment of cd47+ disease cells with sirp alpha-fc fusions
06/26/2014WO2014071074A3 Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
06/26/2014WO2014067011A8 Crystal structures of heterodimeric fc domains
06/26/2014WO2014066744A3 Anti-complement c1s antibodies and uses thereof
06/26/2014WO2014047222A9 Methods for identifying antibodies with reduced immunogenicity
06/26/2014WO2013153457A4 Rapid test for cellular fibronectin
06/26/2014WO2013101451A8 Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
06/26/2014US20140179907 Anti-cd40 antibodies
06/26/2014US20140179906 Conjugation methods
06/26/2014US20140179905 Methods and compositions for targeting polyubiquitin
06/26/2014US20140179904 Protein purification using hcic and ion exchange chromatography
06/26/2014US20140179903 High Affinity Human Antibodies to Human Protease-Activated Receptor 2
06/26/2014US20140179558 Method for detecting pancreatic cancer
06/26/2014US20140179547 Methods For The Generation Of Multispecific And Multivalent Antibodies
06/26/2014US20140178936 Humanized Anti-CD70 Binding Agents and Uses Thereof
06/26/2014US20140178935 Hepatocyte growth factor (hgf) binding proteins
06/26/2014US20140178934 Hepatocyte growth factor (hgf) binding proteins
06/26/2014US20140178855 Murine Astroviruses
06/26/2014US20140178417 Methods for treating cancer using an immunotoxin
06/26/2014US20140178415 Maytansinoid derivatives
06/26/2014US20140178414 Maytansinoid derivatives
06/26/2014US20140178410 Antibodies against phosphorylcholine
06/26/2014US20140178409 Sema5b peptides and vaccines including the same
06/26/2014US20140178408 Method of producing an antibody
06/26/2014US20140178406 Use of goat serum for veterinary treatment
06/26/2014US20140178405 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
06/26/2014US20140178403 Method of inhibiting binding or activity of mif by administering a mif antagonist
06/26/2014US20140178402 Pharmaceutical compositions comprising human antibodies to pcsk9
06/26/2014US20140178401 Anti-il-23 antibodies
06/26/2014US20140178399 Role of adam10 and its relevance to disease and therapeutics
06/26/2014US20140178398 Vascular disruption agents and uses thereof
06/26/2014US20140178397 Anti-angiogenic therapy
06/26/2014US20140178395 Treatment of nephropathy
06/26/2014US20140178394 Novel antigen peptide and uses thereof
06/26/2014US20140178393 Amino acid sequence presenting fusion polypeptide and its use
06/26/2014US20140178392 Nogo Receptor-Mediated Blockade of Axonal Growth
06/26/2014US20140178391 Colon disease targets and uses thereof
06/26/2014US20140178390 Biological materials related to cxcr7
06/26/2014US20140178389 Il-1 binding proteins
06/26/2014US20140178388 Multivalent antibody fragments and trimerized complexes thereof
06/26/2014US20140178387 Antibody molecules having binding specificity for human il-13
06/26/2014US20140178386 Functionalized polypeptides
06/26/2014US20140178385 Generation of Anti-FN14 Monoclonal Antibodies by Ex-Vivo Accelerated Antibody Evolution
06/26/2014US20140178384 Post-translationally modified neurotrophins
06/26/2014US20140178382 Antibodies against monocyte chemotactic proteins
06/26/2014US20140178380 Bi-Specific Fusion Proteins
06/26/2014US20140178378 Sgp130/fc dimers
06/26/2014US20140178377 Methods and compositions for treatment of myotonic dystrophy
06/26/2014US20140178375 Antibody-like proteins for therapeutic and diagnostic use
06/26/2014US20140178373 Pharmaceutical composition for treatment and/or prophylaxis of cancer
06/26/2014US20140178372 Methods of treating hematologic cancers
06/26/2014US20140178371 Anti-angiogenesis therapy for the treatment of ovarian cancer
06/26/2014US20140178370 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
06/26/2014US20140178369 Treatment with anti-vegf antibodies
06/26/2014US20140178368 Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
06/26/2014US20140178367 Methods of Treating Inflammatory Diseases by Targeting the Chemoattractant Cytokine Receptor 2 (CCR2) or Chemokine (C-C motif) Ligand 2 (CCL2)
06/26/2014US20140178366 Preselection of subjects for therapeutic treatment based on hypoxic status
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 1494